| TTM
|
3/31/2026
|
3/31/2025
|
3/31/2024
|
3/31/2023
|
|
|---|---|---|---|---|---|
| Total Revenue
|
5,141.50 | 4,723.77 | 3,329.26 | 8,037.11 | 9,695.40 |
| Cost of Revenue
|
-3,548.76 | -3,707.08 | -3,083.03 | -3,685.60 | -3,828.58 |
|
Gross Profit
|
1,592.73 | 1,016.69 | 246.23 | 4,351.50 | 5,866.82 |
| Selling, General and Administrative Expenses
|
-3,067.80 | -2,206.61 | -2,916.04 | -3,072.90 | -2,248.59 |
| Provision Expense/Write-Back
|
633.30 | 633.30 | -2,839.91 | -170.64 | 0 |
| Other Income/Expense, Operating
|
-138.70 | -120.70 | -57.11 | -120.11 | -188.96 |
|
Operating Income/Expenses
|
-2,573.20 | -1,694.01 | -5,813.05 | -3,363.65 | -2,437.56 |
|
Total Operating Profit/Loss
|
-980.47 | -677.32 | -5,566.82 | 987.85 | 3,429.26 |
| Irregular Income/Expenses
|
-500 | -500 | -256.42 | 0 | 0 |
|
Non-Operating Income/Expenses, Total
|
-500 | -500 | -256.42 | 0 | 0 |
|
Pretax Income
|
-1,480.47 | -1,177.32 | -5,823.24 | 987.85 | 3,429.26 |
|
Provision for Income Tax
|
274.93 | 1.78 | -146.10 | 63.69 | -31.52 |
|
Net Income from Continuing Operations
|
-1,205.54 | -1,175.54 | -5,969.35 | 1,051.54 | 3,397.74 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-1,205.54 | -1,175.54 | -5,969.35 | 1,051.54 | 3,397.74 |
|
Non-Controlling/Minority Interests
|
5.01 | 4.72 | 0 | -- | -- |
|
Net Income after Non-Controlling/Minority Interests
|
-1,200.53 | -1,170.82 | -5,969.35 | 1,051.54 | 3,397.74 |
|
Net Income Available to Common Stockholders
|
-1,200.53 | -1,170.82 | -5,969.35 | 1,051.54 | 3,397.74 |
|
Diluted Net Income Available to Common Stockholders
|
-1,200.53 | -1,170.82 | -5,969.35 | 1,051.54 | 3,397.74 |
| Basic EPS
|
-0.18 | -0.15 | -0.80 | 0.15 | 0.50 |
| Diluted EPS
|
-0.18 | -0.15 | -0.80 | 0.15 | 0.50 |
|
Basic Weighted Average Shares Outstanding
|
7,435.36 | 7,414.85 | 7,406.28 | 6,455.70 | 6,833.18 |
|
Diluted Weighted Average Shares Outstanding
|
7,435.36 | 7,414.85 | 7,406.28 | 6,455.70 | 6,833.18 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-1,480.47 | -1,177.32 | -5,823.24 | 987.85 | 3,429.26 |
|
EBITDA
|
-650.50 | -716.32 | -5,647.35 | 1,132.34 | 3,550.21 |
|
Normalized EBITDA
|
-91.73 | -305.14 | -5,295.25 | 720.17 | 3,600.35 |
|
Normalized Income
|
-750.53 | -764.98 | -5,617.24 | 639.36 | 3,447.42 |
|
Total Unusual Items
|
558.77 | 411.18 | 352.11 | -412.18 | 50.14 |
|
Total Unusual Items Excluding Goodwill
|
558.77 | 411.18 | 352.11 | -412.18 | 50.14 |
|
Tax Effect of Unusual Items
|
103.77 | 0.62 | 0 | 0 | 0.46 |
3/31/2023 - 6/1/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade